Susunod

Auto-play

Dendritic Cell Vaccination in Treatment of Relapsed Pediatric AML

2 Mga view • 07/04/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Despite allogeneic hematopoietic cell transplantation the survival chances in pediatric AML are 50% only. With the developed adjuvant WT1 Cord Blood Derived Dendritic Cell Vaccine the survival chances may increase. The clinical study will start early 2017.
PIs: Dr Jaap Jan Boelens (clinical / translational) and Dr Stefan Nierkens (lab / translational)

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play